Keith Hinton

Stock Analyst at Freedom Capital Markets

(2.55)
# 2,951
Out of 5,044 analysts
20
Total ratings
53.8%
Success rate
5.5%
Average return

Stocks Rated by Keith Hinton

AtriCure
Oct 2, 2026
Downgraded: Hold
Price Target: $43 → $57
Current: $55.81
Upside: +2.13%
Cerebras Systems
Oct 2, 2026
Upgraded: Buy
Price Target: $209
Current: $164.17
Upside: +27.31%
Inspire Medical Systems
Sep 21, 2026
Reiterated: Buy
Price Target: $62 → $97
Current: $68.89
Upside: +40.80%
Veracyte
Sep 15, 2026
Reiterated: Buy
Price Target: $45 → $66
Current: $45.23
Upside: +45.92%
Pulse Biosciences
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $73
Current: $53.81
Upside: +35.66%
Enovis
Sep 1, 2026
Reiterated: Buy
Price Target: $45 → $36
Current: $17.69
Upside: +103.50%
Globus Medical
Aug 27, 2026
Reiterated: Hold
Price Target: $87
Current: $74.65
Upside: +16.54%
LivaNova
Aug 20, 2026
Reiterated: Hold
Price Target: $81 → $75
Current: $76.39
Upside: -1.82%
LeMaitre Vascular
Aug 14, 2026
Reiterated: Hold
Price Target: $81
Current: $80.69
Upside: +0.38%
Alphatec Holdings
Aug 12, 2026
Reiterated: Buy
Price Target: $25 → $17
Current: $10.67
Upside: +59.33%
Reiterated: Buy
Price Target: $102
Current: $67.33
Upside: +51.49%
Downgraded: Hold
Price Target: $112 → $127
Current: $126.61
Upside: +0.31%